Mufg Securities Americas Inc. bought a new stake in Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 16,620 shares of the company's stock, valued at approximately $534,000.
Several other hedge funds have also recently added to or reduced their stakes in the company. New Age Alpha Advisors LLC grew its stake in shares of Keurig Dr Pepper by 82.8% during the 4th quarter. New Age Alpha Advisors LLC now owns 859 shares of the company's stock worth $28,000 after purchasing an additional 389 shares during the period. Whipplewood Advisors LLC purchased a new stake in shares of Keurig Dr Pepper during the 4th quarter valued at about $37,000. Edmond DE Rothschild Holding S.A. purchased a new position in shares of Keurig Dr Pepper in the fourth quarter valued at $42,000. LRI Investments LLC grew its holdings in Keurig Dr Pepper by 65.6% during the 4th quarter. LRI Investments LLC now owns 1,527 shares of the company's stock valued at $49,000 after purchasing an additional 605 shares in the last quarter. Finally, Brooklyn Investment Group increased its stake in Keurig Dr Pepper by 34.0% during the 4th quarter. Brooklyn Investment Group now owns 2,184 shares of the company's stock worth $70,000 after buying an additional 554 shares during the period. Institutional investors and hedge funds own 93.99% of the company's stock.
Keurig Dr Pepper Stock Up 0.0%
KDP traded up $0.01 during midday trading on Monday, hitting $33.83. 8,217,014 shares of the company's stock traded hands, compared to its average volume of 10,542,943. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.53 and a quick ratio of 0.36. The company has a market cap of $45.95 billion, a PE ratio of 20.50, a price-to-earnings-growth ratio of 2.42 and a beta of 0.52. Keurig Dr Pepper Inc. has a one year low of $30.12 and a one year high of $38.28. The stock's fifty day simple moving average is $34.22 and its 200-day simple moving average is $33.01.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.04. The company had revenue of $3.64 billion for the quarter, compared to analyst estimates of $3.57 billion. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The business's revenue was up 4.8% compared to the same quarter last year. During the same period last year, the company earned $0.38 earnings per share. As a group, equities analysts anticipate that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, VP Angela A. Stephens sold 14,500 shares of the stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $34.24, for a total value of $496,480.00. Following the completion of the sale, the vice president now directly owns 62,411 shares of the company's stock, valued at approximately $2,136,952.64. This represents a 18.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Bevco B.V. Jab sold 83,950,000 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $32.65, for a total transaction of $2,740,967,500.00. Following the completion of the sale, the insider now owns 134,113,479 shares in the company, valued at approximately $4,378,805,089.35. The trade was a 38.50% decrease in their position. The disclosure for this sale can be found here. Insiders sold 84,863,850 shares of company stock valued at $2,772,203,450 over the last 90 days. 0.40% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on KDP. Argus initiated coverage on shares of Keurig Dr Pepper in a report on Wednesday, April 16th. They issued a "buy" rating and a $40.00 price target on the stock. Wells Fargo & Company reissued an "overweight" rating on shares of Keurig Dr Pepper in a report on Tuesday, February 25th. Morgan Stanley upgraded Keurig Dr Pepper from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $38.00 to $40.00 in a research report on Tuesday, April 1st. Barclays lifted their price target on Keurig Dr Pepper from $37.00 to $38.00 and gave the company an "overweight" rating in a report on Monday, April 28th. Finally, Hsbc Global Res upgraded Keurig Dr Pepper from a "hold" rating to a "strong-buy" rating in a research report on Friday, April 25th. Four equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, Keurig Dr Pepper currently has an average rating of "Moderate Buy" and a consensus target price of $39.33.
Check Out Our Latest Research Report on Keurig Dr Pepper
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Articles

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.